WFDC2 (HE4) and SLPI are differentially expressed in normal and diseased human lung and in lung cancer

C. D. Bingle, S. S. Cross, A. S. High, W. A. Wallace, D. Rassl, L. Bingle (Sheffield, Leeds, Edinburgh, Cambridge, United Kingdom)

Source: Annual Congress 2006 - Molecular airway biology
Session: Molecular airway biology
Session type: Oral Presentation
Number: 956

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. D. Bingle, S. S. Cross, A. S. High, W. A. Wallace, D. Rassl, L. Bingle (Sheffield, Leeds, Edinburgh, Cambridge, United Kingdom). WFDC2 (HE4) and SLPI are differentially expressed in normal and diseased human lung and in lung cancer. Eur Respir J 2006; 28: Suppl. 50, 956

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Telomerase expression in idiopathic pulmonary fibrosis (IPF) and non small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012

SFTPA mutations in interstitial lung disease (ILD) and lung cancer
Source: International Congress 2017 – Rare diseases
Year: 2017

Distinct forms of BARD1 expressed in lung fibrosis and lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 325s
Year: 2006

The association of lung cancer with pulmonary fibrosis
Source: ERJ Open Res, 8 (1) 00505-2021; 10.1183/23120541.00505-2021
Year: 2022



KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

mRNA expression of YY1, TNF-α a TGF-β in lung samples gained by transbronchial biopsies (TBB) in patients with different interstitial lung diseases (ILDs)
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Lung cancer: immunopathology
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48
Year: 2001

The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005

Tumor-derived tumor necrosis factor-α promotes Lewis lung cancer-induced malignant pleural effusions in mice
Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer
Year: 2006


p16INK4a promoter hypermethylation in tissue, blood, and sputum from non-small cell lung cancer and pulmonary inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 813s
Year: 2006

Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing
Source: Eur Respir J 2004; 24: 502-505
Year: 2004



Homeobox-genes (HOX) in human lung - altered expression in lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 477s
Year: 2001

Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


Interstitial fibrosis with a nodule
Source: Annual Congress 2007 - Thoracic Oncology Grand Round: an interactive session
Year: 2007

Looking for airways periostin in patients with interstitial lung diseases.
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Intersections of lung progenitor cells, lung disease and lung cancer
Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017
Year: 2017